🇺🇸 FDA
Patent

US 11446383

Lipid formulations for delivery of therapeutic agents

granted A61KA61K31/713A61K47/44

Quick answer

US patent 11446383 (Lipid formulations for delivery of therapeutic agents) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/713, A61K47/44, A61K47/543, A61K9/0019